Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Romina Bester"'
Autor:
Bo-Hung Liao, Louise Platen, Myriam Grommes, Cho-Chin Cheng, Christopher Holzmann-Littig, Catharina Christa, Bernhard Haller, Verena Kappler, Romina Bester, Maia Lucia Werz, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines, Vol 12, Iss 3, p 308 (2024)
Background: Hemodialysis patients have reduced serologic immunity after SARS-CoV-2 vaccination compared to the general population and an increased risk of morbidity and mortality when exposed to SARS-CoV-2. Methods: Sixty-six hemodialysis patients im
Externí odkaz:
https://doaj.org/article/94485bd5f28543fe83352e3af06f68fa
Autor:
Anna Nieborak, Saulius Lukauskas, Jordi Capellades, Patricia Heyn, Gabriela Silva Santos, Karsten Motzler, Anja Zeigerer, Romina Bester, Ulrike Protzer, Florian Schelter, Mirko Wagner, Thomas Carell, Alexander Hruscha, Bettina Schmid, Oscar Yanes, Robert Schneider
Publikováno v:
Molecular Metabolism, Vol 74, Iss , Pp 101748- (2023)
Objective: Cancer cells convert more glucose into lactate than healthy cells, what contributes to their growth advantage. Pyruvate kinase (PK) is a key rate limiting enzyme in this process, what makes it a promising potential therapeutic target. Howe
Externí odkaz:
https://doaj.org/article/1cdb8cc6c3104464995700a9b14eb2eb
Autor:
Hristo L. Svilenov, Romina Bester, Julia Sacherl, Ramona Absmeier, Carsten Peters, Ulrike Protzer, Carsten Brockmeyer, Johannes Buchner
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-7 (2022)
Fusion of ACE2 to IgM-Fc results in hexameric ACE2-IgM-Fc proteins with potent virus neutralization efficiency of patient-isolated SARS-CoV and SARS-CoV-2 variants.
Externí odkaz:
https://doaj.org/article/531c1bbc362d430f988e33a1452a8425
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1328 (2022)
Hemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date, it is unclear if hemodialysis patients benefit from four vaccinations. A total of 142 hemodialysis patients received four COVID-19 vaccinations unt
Externí odkaz:
https://doaj.org/article/1fdcbc0627d14e36a5986b2ecef6e6a7
Autor:
Andrea Fehlinger, Hanna Wolf, André Hossinger, Yvonne Duernberger, Catharina Pleschka, Katrin Riemschoss, Shu Liu, Romina Bester, Lydia Paulsen, Suzette A. Priola, Martin H. Groschup, Hermann M. Schätzl, Ina M. Vorberg
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract Prions are unconventional agents composed of misfolded prion protein that cause fatal neurodegenerative diseases in mammals. Prion strains induce specific neuropathological changes in selected brain areas. The mechanism of strain-specific ce
Externí odkaz:
https://doaj.org/article/13fe002f36ce4b6588374aa799d3ba3e
Autor:
Louise Platen, Bo-Hung Liao, Myriam Tellenbach, Cho-Chin Cheng, Christopher Holzmann-Littig, Catharina Christa, Christopher Dächert, Verena Kappler, Romina Bester, Maia Lucia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Oliver T. Keppler, Lutz Renders, Matthias Christoph Braunisch, Ulrike Protzer
BackgroundIndividuals on hemodialysis are more vulnerable to SARS-CoV-2 infection than the general population due to end-stage kidney disease-induced immunosuppression.Methods26 hemodialysis patients experiencing SARS-CoV-2 infection after 3rdvaccina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::404c1b129e2ac533f383b7687aef6fb4
https://doi.org/10.1101/2023.03.14.23287246
https://doi.org/10.1101/2023.03.14.23287246
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
BackgroundHemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date it is unclear if hemodialysis patients benefit from a fourth vaccination.MethodsA total of 142 hemodialysis patients (median age 72.6 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e914dcb956894f2ccc8065a769c97865
https://doi.org/10.1101/2022.06.22.22276787
https://doi.org/10.1101/2022.06.22.22276787
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines; Volume 10; Issue 8; Pages: 1328
Vaccines 10:1328 (2022)
Vaccines 10:1328 (2022)
Hemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date, it is unclear if hemodialysis patients benefit from four vaccinations. A total of 142 hemodialysis patients received four COVID-19 vaccinations unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a73ae10d574d217cdbf5962955af4f1
https://mediatum.ub.tum.de/1689301
https://mediatum.ub.tum.de/1689301
Autor:
Marc Ringelhan, Firat Nebioglu, Christian Urban, Arie Geerlof, Jochen M. Wettengel, Martin Kächele, Maarten van de Klundert, Kristian Unger, Jessica Schneider, Julia Hess, Yuchen Xia, Andreas Oswald, Chunkyu Ko, Alisha N Jones, Felix Lasitschka, Peter Schirmacher, Ralf Bartenschlager, Mathias Heikenwalder, Ulrike Protzer, Daniela Stadler, Wen-Min Chou, Michael Sattler, Sabrina Schreiner, Romina Bester, Andreas Pichlmair
Publikováno v:
EMBO Reports
EMBO Rep. 22:e49568 (2021)
EMBO Rep. 22:e49568 (2021)
Hepatitis B virus (HBV) persists by depositing a covalently closed circular DNA (cccDNA) in the nucleus of infected cells that cannot be targeted by available antivirals. Interferons can diminish HBV cccDNA via APOBEC3‐mediated deamination. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36359062d0944dc463aae4603ed816b3
https://mediatum.ub.tum.de/doc/1624648/document.pdf
https://mediatum.ub.tum.de/doc/1624648/document.pdf
Autor:
Marc Ringelhan, Chunkyu Ko, Maarten van de Klundert, Ke Zhang, Silke Arzberger, Maria Quasdorff, Carien M. Niessen, Ulrike Protzer, Margarete Odenthal, Gesa von Olshausen, Romina Bester
Publikováno v:
Oncotarget
Oncotarget 9, 33947-33960 (2018)
Oncotarget 9, 33947-33960 (2018)
Hepatitis B virus (HBV) infection is a prominent cause of hepatocellular carcinoma (HCC) but the underlying molecular mechanisms are complex and multiple pathways have been proposed such as the activation of the Wnt-/β-catenin-signalling and dysregu